Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months

BACKGROUND: Bronchial asthma is a heterogeneous disease characterized by three cardinal features: chronic inflammation, variable airflow obstruction, and airway hyperresponsiveness. Asthma has traditionally been defined using nonspecific clinical and physiologic variables that encompass multiple phe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Transl Allergy
Main Authors: Riccio, Anna Maria, Mauri, Pierluigi, De Ferrari, Laura, Rossi, Rossana, Di Silvestre, Dario, Benazzi, Louise, Chiappori, Alessandra, Dal Negro, Roberto Walter, Micheletto, Claudio, Canonica, Giorgio Walter
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2017
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5345272/
https://ncbi.nlm.nih.gov/pubmed/28293414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13601-017-0143-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares